Kairos Pharma, LTD. (KAPA) — 10-K/A Filings
All 10-K/A filings from Kairos Pharma, LTD.. Browse 2 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (2)
-
Kairos Pharma Files 10-K/A Amendment for FY24 Report
— Jul 28, 2025 Risk: medium
Kairos Pharma, LTD. (KAPA) filed a 10-K/A Amendment No. 2 for the fiscal year ended December 31, 2024, indicating corrections or updates to its previously filed -
Kairos Pharma Files 2024 Annual Report Amendment
— Apr 29, 2025 Risk: low
Kairos Pharma, LTD. filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2024. The company, incorporated in Delaware with it
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX